Back to results
US 6,596,900 B2Granted
Fused bicyclic or tricyclic amino acids
AssigneePfizer Inc.
InventorsDavid Clive Blakemore, Justin Stephen Bryans, Sophie Caroline Williams
Life of this patent
Estimating the term…
Abstract
The compounds of the instant invention are bicyclic or tricyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, sleep disorders, visceral pain disorders, and gastrointestinal disorders. Processes for the preparation of the final products and intermediates useful in the process are included. Pharmaceutical compositions containing one or more of the compounds are also included.
Claims9
A compound of any of the formulae I-XXV:
- wherein R1 and R2 are each independently selected from hydrogen, straight or branched alkyl of 1-6 carbon atoms, cycloalkyl of from 3-6 carbon atoms, phenyl and benzyl, subject to the proviso that except in the case of a tricyclooctane compound of formula (XVII) R1 and R2 are not simultaneously hydrogen;
- or a pharmaceutically acceptable salt or solvate thereof;
- or a prodrug thereof.
Dependencies are inferred from the claim text.